545 related articles for article (PubMed ID: 18825752)
1. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.
Schreiner B; Bailey SL; Shin T; Chen L; Miller SD
Eur J Immunol; 2008 Oct; 38(10):2706-17. PubMed ID: 18825752
[TBL] [Abstract][Full Text] [Related]
2. B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis.
Ortler S; Leder C; Mittelbronn M; Zozulya AL; Knolle PA; Chen L; Kroner A; Wiendl H
Eur J Immunol; 2008 Jun; 38(6):1734-44. PubMed ID: 18421793
[TBL] [Abstract][Full Text] [Related]
3. The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.
Cheng X; Zhao Z; Ventura E; Gran B; Shindler KS; Rostami A
J Neuroimmunol; 2007 Apr; 185(1-2):75-86. PubMed ID: 17320975
[TBL] [Abstract][Full Text] [Related]
4. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
[TBL] [Abstract][Full Text] [Related]
5. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ
J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
7. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.
Carter LL; Leach MW; Azoitei ML; Cui J; Pelker JW; Jussif J; Benoit S; Ireland G; Luxenberg D; Askew GR; Milarski KL; Groves C; Brown T; Carito BA; Percival K; Carreno BM; Collins M; Marusic S
J Neuroimmunol; 2007 Jan; 182(1-2):124-34. PubMed ID: 17182110
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
[TBL] [Abstract][Full Text] [Related]
9. Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.
Seo SK; Seo HM; Jeong HY; Choi IW; Park YM; Yagita H; Chen L; Choi IH
Immunol Lett; 2006 Feb; 102(2):222-8. PubMed ID: 16236366
[TBL] [Abstract][Full Text] [Related]
10. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals.
Kim HK; Guan H; Zu G; Li H; Wu L; Feng X; Elmets C; Fu Y; Xu H
J Leukoc Biol; 2006 Apr; 79(4):686-95. PubMed ID: 16461745
[TBL] [Abstract][Full Text] [Related]
11. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
12. B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral tolerance.
Waisman A; Yogev N
Eur J Immunol; 2009 Jun; 39(6):1448-51. PubMed ID: 19499529
[TBL] [Abstract][Full Text] [Related]
13. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
[TBL] [Abstract][Full Text] [Related]
14. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.
Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R
Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673
[TBL] [Abstract][Full Text] [Related]
15. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.
Duncan DS; Miller SD
PLoS One; 2011 Apr; 6(4):e18548. PubMed ID: 21494618
[TBL] [Abstract][Full Text] [Related]
16. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.
Latchman YE; Liang SC; Wu Y; Chernova T; Sobel RA; Klemm M; Kuchroo VK; Freeman GJ; Sharpe AH
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10691-6. PubMed ID: 15249675
[TBL] [Abstract][Full Text] [Related]
17. Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis.
Ren Y; Lu L; Guo TB; Qiu J; Yang Y; Liu A; Zhang JZ
J Immunol; 2008 Jul; 181(2):1491-8. PubMed ID: 18606704
[TBL] [Abstract][Full Text] [Related]
18. B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.
Brandl C; Ortler S; Herrmann T; Cardell S; Lutz MB; Wiendl H
PLoS One; 2010 May; 5(5):e10800. PubMed ID: 20520738
[TBL] [Abstract][Full Text] [Related]
19. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.
Tsushima F; Iwai H; Otsuki N; Abe M; Hirose S; Yamazaki T; Akiba H; Yagita H; Takahashi Y; Omura K; Okumura K; Azuma M
Eur J Immunol; 2003 Oct; 33(10):2773-82. PubMed ID: 14515261
[TBL] [Abstract][Full Text] [Related]
20. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
